3
CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 125083Orig1s000 OFFICE DIRECTOR MEMO

APPLICATION NUMBER: 125083Orig1s000 · 2011. 9. 16. · Hoffiann-La Roche (HLR) has submitted this original BLA relating to the combination use of pegylated interferon alfa-2a (Pegasys)

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: APPLICATION NUMBER: 125083Orig1s000 · 2011. 9. 16. · Hoffiann-La Roche (HLR) has submitted this original BLA relating to the combination use of pegylated interferon alfa-2a (Pegasys)

CENTER FOR DRUG EVALUATION AND RESEARCH

APPLICATION NUMBER: 125083Orig1s000

OFFICE DIRECTOR MEMO

Page 2: APPLICATION NUMBER: 125083Orig1s000 · 2011. 9. 16. · Hoffiann-La Roche (HLR) has submitted this original BLA relating to the combination use of pegylated interferon alfa-2a (Pegasys)
Page 3: APPLICATION NUMBER: 125083Orig1s000 · 2011. 9. 16. · Hoffiann-La Roche (HLR) has submitted this original BLA relating to the combination use of pegylated interferon alfa-2a (Pegasys)